Together, these data suggest that combination treatment with IAP and WEE1 inhibitors results in a small but significant reduction in NFκB activity, and this may contribute to the increased sensitivity of TNFα-induced cyctotoxicity observed in HNSCC cells. The gene discussed is TNF; the disease is head and neck squamous cell carcinoma.